Successful six-day kidney preservation using trophic factor supplemented media and simple cold storage

American Journal of Transplantation

Volumn 2, Issue 8, 2002, Pages 712-718

  McAnulty, Jonathan F ^a   Reid, Ted W ^b   Waller, Ken R ^a   Murphy, Christopher J ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

Author keywords

Bactenecin; Cold storage; Dog; Epidermal growth factor; Insulin like growth factor 1; Kidney; Nerve growth factor; Substance P; Transplantation; Trophic factors

Indexed keywords

BACTENECIN; CREATININE; EPIDERMAL GROWTH FACTOR; GROWTH FACTOR; NERVE GROWTH FACTOR; SOMATOMEDIN C; SUBSTANCE P; UNIVERSITY OF WISCONSIN SOLUTION;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CRYOPRESERVATION; DOG; FEMALE; KIDNEY FUNCTION; KIDNEY PRESERVATION; KIDNEY TRANSPLANTATION; MALE; NONHUMAN; ORGAN TRANSPLANTATION; TREATMENT OUTCOME;

ADENOSINE; ALLOPURINOL; ANIMALS; COLD; DOGS; EPIDERMAL GROWTH FACTOR; FEMALE; GLUTATHIONE; INSULIN; INSULIN-LIKE GROWTH FACTOR I; KIDNEY; MALE; NERVE GROWTH FACTOR; ORGAN PRESERVATION; ORGAN PRESERVATION SOLUTIONS; PEPTIDES, CYCLIC; RAFFINOSE; SUBSTANCE P;

EID: 0036766645     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-6143.2002.20805.x     Document Type: Article

References (68)

1. Matas AJ, Gillingham KJ, Humar A, Dunn DL, Sutherland DE, Najarian JS. Immunologic and nonimmunologic factors: different risks for cadaver and living donor transplantation. Transplantation 2000; 69: 54-58.
2. Koning OH, Ploeg RJ, van Bockel JH et al. Risk factors for delayed graft function in cadaveric kidney transplantation: a prospective study of renal function and graft survival after preservation with University of Wisconsin solution in multi-organ donors. European Multicenter Study Group. Transplantation 1997; 63: 1620-1628.
3. Ojo AO, Wolfe RA, Held PJ, Port FK, Schmouder RL, Delayed graft function: risk factors and implications for renal allograft survival. Transplantation 1997; 63: 968-974.
4. Tejani AH, Sullivan EK, Alexander SR, Fine RN, Harmon WE, Kohaut EC. Predictive factors for delayed graft function (DGF) and its impact on renal graft survival in children: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Transplant 1999; 3: 293-300.
5. Belzer FO, Ashby BS, Dunphy JE. 24-hour and 72-hour preservation of canine kidneys. Lancet 1967; ii: 536-539.
6. Collins GM, Bravo-Shugarman M, Terasaki PI. Kidney preservation for transportation. Lancet 1969; ii: 1219-1222.
7. Wahlberg JA, Southard JH, Belzer FO. Development of a cold storage solution for pancreas preservation. Cryobiology 1986; 23: 477-482.
8. Wahlberg JA, Love R, Landegaard L, Southard JH, Belzer FO. 72-hour preservation of the canine pancreas. Transplantation 1987; 43: 5-8.
9. Jamieson NV, Sundberg R, Lindell S, Southard JH, Belzer FO. A comparison of cold storage solutions for hepatic preservation using the isolated perfused rabbit liver. Cryobiology 1988; 25: 300-310.
10. Ploeg RJ, Goosens D, McAnulty JF, Southard JH, Belzer FO. Successful 72-hour cold storage of dog kidneys with UW solution. Transplantation 1988; 46: 191-196.
11. Williams GT, Smith CA, Spooncer E, Dexter TM, Taylor DR. Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis. Nature 1990; 343: 76-78.
12. Wyllie AH. Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: an overview. Cancer Metastasis Rev 1992; 11: 95-103.
13. Zhou XM, Liu Y, Payne G, Lutz RJ, Chittenden T. Growth factors inactivate the cell death promoter BAD by phosphorylation of its BH3 domain on Ser155. J Biol Chem 2000; 275: 25046-25051.
14. McAnulty JF, Southard JH, Belzer FO. Prevention of postoperative intussusception by prophylactic morphine administration in dogs used for organ transplantation research. Surgery 1989; 105: 494-495.
15. McAnulty JF, Ploeg RJ, Southard JH, Belzer FO. Successful 5-day perfusion preservation of the canine kidney. Transplantation 1989; 47: 37-41.
16. Gan BS, MacCannell KL, Hollenberg MD. Epidermal growth factor-urogastrone causes vasodilatation in the anesthetized dog. J Clin Invest 1987; 80: 199-206.
17. Petrinec D, Reilly JM, Sicard GA et al. Insulin-like growth factor-I attenuates delayed graft function in a canine renal autotransplantation model. Surgery 1996; 120: 221-225.
18. Maestri M, Dafoe DC, Adams GA et al. Insulin-like growth factor-I ameliorates delayed kidney graft function and the acute nephrotoxic effects of cyclosporine. Transplantation 1997; 64: 185-190.
19. Schwab IR, Dries D, Cullor J et al. Corneal storage medium preservation with defensins. Cornea 1992; 11: 370-375.
20. Chan EY, Stang SL, Bottorff DA, Stone JC. Hypothermic stress leads to activation of Ras-Erk signaling. J Clin Invest 1999; 103: 1337-1344.
21. Arai S, Mochida S, Ohno A et al. Decreased expression of receptors for vascular endothelial growth factor and sinusoidal endothelial cell damage in cold-preserved rat livers. Transplant Proc 1999; 31: 2668-2672.
22. Wilhelm SM, Simonson MS, Robinson AV, Stowe NT, Schulak JA. Cold ischemia induces endothelin gene upregulation in the preserved kidney. J Surg Res 1999; 85: 101-108.
23. Wagerle LC, Kim SJ, Russo P. Protein tyrosine kinase signaling in cold-stimulated contraction of newborn lamb cerebral arteries. Am J Physiol 1996; 270: H645-H650.
24. Dahdah NS, Russo P, Wagerle LC. Phosphorylation in coronary artery cold-induced contraction in the newborn lamb. Cryobiology 2001; 42: 40-48.
25. Romeo D, Skerlavaj B, Bolognesi M, Gennaro R. Structure and bactericidal activity of an antibiotic dodecapeptide purified from bovine neutrophils. J Biol Chem 1988; 263: 9573-9575.
26. Daher KA, Selsted ME, Lehrer RI. Direct inactivation of viruses by human granulocyte defensins. J Virol 1986; 60: 1068-1074.
27. Lehrer RI, Lichtenstein AK, Ganz T. Defensins: antimicrobial and cytotoxic peptides of mammalian cells. Ann Rev Immunol 1993; 11: 105-128.
28. Wimley WC, Selsted ME, White SH. Interactions between human defensins and lipid bilayers: evidence for formation of multimeric pores. Protein Sci 1994; 3: 1362-1373.
29. Zhu OZ, Singh AV, Bateman A, Esch F, Solomon S. The corticostatic (anti-ACTH) and cytotoxic activity of peptides isolated from fetal, adult and tumor-bearing lung. J Steroid Biochem 1987; 27: 1017-1022.
30. Murphy CJ, Foster BA, Mannis MJ, Selsted ME, Reid TW. Defensins are mitogenic for epithelial cells and fibroblasts. J Cell Physiol 1993; 155: 408-413.
31. Charp PA, Rice WG, Raynor RL et al. Inhibition of protein kinase C by defensins, antibiotic peptides from human neutrophils. Biochem Pharmacol 1988; 37: 951-956.
32. Tkachenko SB, Kokriakov VN, Ashmarin IP, Grachev SV, Kubatiev AA. The effect of human defensins on the level of cytoplasmic Ca2+ in platelets. Bull Exp Biol Med 1994; 118: 600-603.
33. Reid TW, Tran P, Nishida T, Murphy CJ, The stimulation of rabbit corneal epithelial cell migration in culture by substance P, is synergistic with insulin and IGF-1. Invest Ophthalmol Vis Sci 1999; 40: s99-s100.
34. Desai BJ, Gruber HE. Anti-apoptotic actions of cytokines in mammalian cells. Proc Soc Exp Biol Med 1999; 221: 1-13.
35. Motyl T. Regulation of apoptosis: involvement of Bcl-2-related proteins. Reprod Nutr Dev 1999; 39: 49-59.
36. Ishibashi Y, Nishimaki K, Asoh S, Nanbu-Wakao R, Yamada T, Ohta S. Pore formation domain of human pro-apoptotic Bax induces mammalian apoptosis as well as bacterial death without antagonizing anti-apoptotic factors. Biochem Biophys Res Commun 1998; 243: 609-616.
37. Reid TW, Murphy CJ, Iwahashi CK, Foster BA, Mannis MJ. Stimulation of epithelial cell growth by the neuropeptide substance P. J Cell Biochem 1993; 52: 476-485.
38. Snijdelaar DG, Dirksen R, Slappendel R, Crul BJ. Substance P. Eur J Pain 2000; 4: 121-135.
39. Zachary I, Rozengurt E. Identification of a receptor for peptides of the bombesin family in Swiss 3T3 cells by affinity cross-linking. J Biol Chem 1987; 252: 3947-3950.
40. Villablanca AC, Murphy CJ, Reid TW. Growth-promoting effects of substance P on endothelial cells in vitro. Synergism with calcitonin gene-related peptide, insulin, and plasma factors. Circ Res 1994; 75: 1113-1120.
41. Bandtlow CE, Heumann R, Schwab ME, Thoenen H. Cellular localization of nerve growth factor synthesis by in situ hybridization. EMBO J 1987; 6: 891-899.
42. Stead RH, Bienenstock J, Stanisz AM, Neuropeptide regulation of mucosal immunity. Immunol Rev 1987; 100: 333-359.
43. Lillien LE, Claude P. Nerve growth factor is a mitogen for cultured chromaffin cells. Nature 1985; 317: 632-634.
44. Yaar M, Gilchrest BA. Human melanocyte growth and differentiation: a decade of new data. J Invest Dermatol 1991; 97: 611-617.
45. Kruse FE, Tseng SC. Growth factors modulate clonal growth and differentiation of cultured rabbit limbal and corneal epithelium. Invest Ophthalmol Vis Sci 1993; 34: 1963-1976.
46. Schlessinger J, Schreiber AB, Levi A, Lax I, Libermann T, Yarden Y. Regulation of cell proliferation by epidermal growth factor. Crit Rev Biochem 1983; 14: 93-111.
47. Nakamura K, Iwamoto R, Mekada E. Membrane-anchored heparin-binding EGF-like growth factor (HB-EGF) and diphtheria toxin receptor-associated protein (DRAP27)/CD9 form a complex with integrin alpha 3 beta 1 at cell-cell contact sites. J Cell Biol 1995: 129: 1691-1705.
48. Edmondson SR, Murashita MM, Russo VC, Wraight CJ, Werther GA. Expression of insulin-like growth factor binding protein-3 (IGFBP-3) in human keratinocytes is regulated by EGF and TGF beta1. J Cell Physiol 1999: 179: 201-207.
49. Gobe G, Zhang XJ, Cuttle L et al. Bcl-2 genes and growth factors in the pathology of ischaemic acute renal failure. Immunol Cell Biol 1999; 77: 279-286.
50. Taub M, Wang Y, Szczesny TM, Kleinman HK. Epidermal growth factor or transforming growth factor alpha is required for kidney tubulogenesis in matrigel cultures in serum-free medium. Proc Natl Acad Sci USA 1990; 87: 4002-4006.
51. Levine L, Hassid A. Epidermal growth factor stimulates prostaglandin biosynthesis by canine kidney (MDCK) cells. Biochem Biophys Res Commun 1977; 76: 1181-1187.
52. Oka A, Tanji N, Toshino A, Miyauchi Y, Yokoyama M. Expression of growth factors after the release of ureteral obstruction in the rat kidney. Internat J Urol 1999; 6: 607-615.
53. Chevalier RL, Goyal S, Thornhill BA. EGF improves recovery following relief of unilateral ureteral obstruction in the neonatal rat. J Urol 1999; 162: 1532-1536.
54. Hirschberg R, Ding H. Growth factors and acute renal failure. Semin Nephrol 1998; 18: 191-207.
55. Ertugrul A, Turkeri LN, Ozyurek M, Ozveri H, Akdas A. Alteration of epidermal growth factor receptor expression following ischaemia of renal tissue. Int Urol Nephrol 1999; 31: 611-617.
56. Takemura T, Kondo S, Homma T, Sakai M, Harris RC. The membranebound form of heparin-binding epidermal growth factor-like growth factor promotes survival of cultured renal epithelial cells. J Biol Chem 1997; 272: 31036-31042.
57. Ethier SP, Kudla A, Cundiff KC. Influence of hormone and growth factor interactions on the proliferative potential of normal rat mammary epithelial cells in vitro. J Cell Physiol 1987; 132: 161-167.
58. Conover CA, Rosenfeld RG, Hintz RL. Hormonal control of the replication of human fetal fibroblasts: role of somatomedin C/insulin-like growth factor I. J Cell Physiol 1986; 128: 47-54.
59. Angervo M, Koistinen R, Seppala M. Epidermal growth factor stimulates production of insulin-like growth factor-binding protein-1 in human granulosa-luteal cells. J Endocrinol 1992; 134: 127-131.
60. Gillespie CM, Merkel AL, Martin AA. Effects of insulin-like growth factor-I and LR31GF-I on regional blood flow in normal rats. J Endocrinol 1997; 155: 351-358.
61. Ren J, Jefferson L, Sowers JR, Brown RA, Influence of age on contractile response to insulin-like growth factor 1 in ventricular myocytes from spontaneously hypertensive rats. Hypertension 1999; 34: 1215-1222.
62. Johnson DW, Brew BK, Poronnik P et al. Insulin-like growth factor I stimulates apical sodium/hydrogen exchange in human proximal tubule cells. Am J Physiol 1997; 272: F484-F490.
63. Miller SB, Martin DR, Kissane J, Hammerman MR. Insulin-like growth factor I accelerates recovery from ischemic acute tubular necrosis in the rat. Proc Natl Acad Sci USA 1992; 89: 11876-11880.
64. Bhaumick B, Bala RM. Binding and degradation of insulin-like growth factors I and II by rat kidney membrane. Endocrinology 1987; 120: 1439-1448.
65. Ding H, Kopple JD, Cohen A, Hirschberg R. Recombinant human insulin-like growth factor-I accelerates recovery and reduces catabolism in rats with ischemic acute renal failure. J Clin Invest 1993; 91: 2281-2287.
66. Di Mari JF, Davis R, Safirstein RL. MAPK activation determines renal epithelial cell survival during oxidative injury. Am J Physiol 1999; 277: F195-F203.
67. Okubo Y, Blakesley VA, Stannard B, Gutkind S, Le RD, Insulin-like growth factor-I inhibits the stress-activated protein kinase/c-Jun N-terminal kinase. J Biol Chem 1998; 273: 25961-25966.
68. Fervenza FC, Tsao T, Hsu F, Rabkin R. Intrarenal insulin-like growth factor-1 axis after unilateral nephrectomy in rat. J Am Soc Nephrol 1999; 10: 43-50.